ENTRY       D01125                      Drug
NAME        Calcipotriene (USP);
            Calcipotriol (JAN);
            Dovonex (TN)
PRODUCT     CALCIPOTRIENE (Mayne Pharma)
            SORILUX (Mayne Pharma)
  GENERIC   CALCIPOTRIENE (Amneal Pharmaceuticals of New York LLC)
            CALCIPOTRIENE (Cosette Pharmaceuticals)
            CALCIPOTRIENE (Fougera Pharmaceuticals)
            CALCIPOTRIENE (Glenmark Pharmaceuticals)
            CALCIPOTRIENE (Glenmark Pharmaceuticals)
            CALCIPOTRIENE (Golden State Medical Supply)
            CALCIPOTRIENE (Golden State Medical Supply)
            CALCIPOTRIENE (Northstar Rx LLC)
            CALCIPOTRIENE (Prasco Laboratories)
            CALCIPOTRIENE (Sandoz)
            CALCIPOTRIENE (Taro Pharmaceuticals U.S.A.)
            CALCITRENE (Taro Pharmaceuticals U.S.A.)
            CALSODORE (FORREAL PHARMACEUTICALS LLC)
FORMULA     C27H40O3
EXACT_MASS  412.2977
MOL_WEIGHT  412.6047
CLASS       Gastrointestinal agent
             DG01607  Vitamin D derivatives
              DG01606  Activated vitamin D3
REMARK      Therapeutic category: 2691
            ATC code: D05AX02
            Chemical structure group: DG00394
            Product (DG00394): D01125<JP/US> D10198<US>
            Product (mixture): D10534<JP/US>
EFFICACY    Antipsoriatic, Vitamin D receptor agonist
  DISEASE   Plaque psoriasis [DS:H01656]
COMMENT     Vitamin D analogue
            synthetic derivative of Calcitriol [CPD:C01673]
TARGET      NR1I1 (VDR) [HSA:7421] [KO:K08539]
  PATHWAY   hsa04961(7421)  Endocrine and other factor-regulated calcium reabsorption
            hsa04978(7421)  Mineral absorption
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D05 ANTIPSORIATICS
               D05A ANTIPSORIATICS FOR TOPICAL USE
                D05AX Other antipsoriatics for topical use
                 D05AX02 Calcipotriol
                  D01125  Calcipotriene (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Psoriasis Agents
                Calcipotriene
                 D01125  Calcipotriene (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2691  Vitamins for external use
                 D01125  Calcipotriene (USP); Calcipotriol (JAN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01607  Vitamin D derivatives
               DG01606  Activated vitamin D3
                DG00394  Calcipotriol
                 D01125  Calcipotriene
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Thyroid hormone like receptors
               Vitamin D3 like receptor
                NR1I1 (VDR)
                 D01125  Calcipotriene (USP) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01125
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01607  Vitamin D derivatives
               DG01606  Activated vitamin D3
                DG00394  Calcipotriol
DBLINKS     CAS: 112965-21-6
            PubChem: 7848188
            ChEBI: 50749
            PDB-CCD: MC9
            LigandBox: D01125
            NIKKAJI: J367.434G
ATOM        30
            1   C1x C    19.6700  -23.3100
            2   C1x C    19.6700  -24.7100
            3   C2y C    20.8600  -25.4100
            4   C1y C    22.1200  -24.7100
            5   C1z C    22.1200  -23.3100
            6   C1x C    20.8600  -22.6100
            7   C1x C    23.4500  -25.1300
            8   C1x C    24.2200  -24.0100
            9   C1y C    23.4500  -22.8900
            10  C1a C    22.1200  -21.9100
            11  C2b C    20.8600  -26.8100
            12  C2b C    19.6700  -27.5100
            13  C2y C    19.6700  -28.9100
            14  C1x C    18.4800  -29.6100
            15  C1y C    18.4800  -31.0100
            16  C1x C    19.6700  -31.7100
            17  C1y C    20.8600  -31.0100
            18  C2y C    20.8600  -29.6100
            19  C2a C    22.0500  -28.9100
            20  O1a O    17.2900  -31.7100
            21  O1a O    22.0500  -31.7100
            22  C1c C    23.8700  -21.5600
            23  C2b C    25.2700  -21.5600
            24  C1a C    23.0300  -20.4400
            25  C2b C    25.9700  -20.3700
            26  C1c C    27.3700  -20.3700
            27  O1a O    28.0700  -21.5600
            28  C1y C    28.0700  -19.1800
            29  C1x C    29.2817  -18.4787
            30  C1x C    28.0797  -17.7994
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    5   9 1
            11    5  10 1 #Up
            12    3  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 1
            19   17  18 1
            20   13  18 1
            21   18  19 2
            22   15  20 1 #Down
            23   17  21 1 #Up
            24    9  22 1
            25   22  23 1
            26   22  24 1 #Down
            27   23  25 2
            28   25  26 1
            29   26  27 1 #Down
            30   26  28 1
            31   28  29 1
            32   29  30 1
            33   30  28 1
///
